OBJECTIVE: Using European descent Czech populations, we performed a study of SLC2A9 and SLC22A12 genes previously identified as being associated with serum uric acid concentrations and gout. This is the first study of the impact of non-synonymous allelic variants on the function of GLUT9 except for patients suffering from renal hypouricemia type 2. METHODS: The cohort consisted of 250 individuals (150 controls, 54 nonspecific hyperuricemics and 46 primary gout and/or hyperuricemia subjects). We analyzed 13 exons of SLC2A9 (GLUT9 variant 1 and GLUT9 variant 2) and 10 exons of SLC22A12 by PCR amplification and sequenced directly. Allelic variants were prepared and their urate uptake and subcellular localization were studied by Xenopus oocytes expression system. The functional studies were analyzed using the non-parametric Wilcoxon and Kruskall-Wallis tests; the association study used the Fisher exact test and linear regression approach. RESULTS: We identified a total of 52 sequence variants (12 unpublished). Eight non-synonymous allelic variants were found only in SLC2A9: rs6820230, rs2276961, rs144196049, rs112404957, rs73225891, rs16890979, rs3733591 and rs2280205. None of these variants showed any significant difference in the expression of GLUT9 and in urate transport. In the association study, eight variants showed a possible association with hyperuricemia. However, seven of these were in introns and the one exon located variant, rs7932775, did not show a statistically significant association with serum uric acid concentration. CONCLUSION: Our results did not confirm any effect of SLC22A12 and SLC2A9 variants on serum uric acid concentration. Our complex approach using association analysis together with functional and immunohistochemical characterization of non-synonymous allelic variants did not show any influence on expression, subcellular localization and urate uptake of GLUT9.

Charles University Prague Faculty of Science Department of Cell Biology Prague Czech Republic

Institute of Inherited Metabolic Disorders 1st Faculty of Medicine Charles University Prague and General University Hospital Prague Prague Czech Republic

Institute of Inherited Metabolic Disorders 1st Faculty of Medicine Charles University Prague and General University Hospital Prague Prague Czech Republic; Institute of Rheumatology Prague Czech Republic

Institute of Rheumatology Prague Czech Republic

Zobrazit více v PubMed

Hayden MR, Suresh CT (2004) Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab (Lond) 1: 10. PubMed PMC

Ebrahimpour P, Hossein F, Ramin H, Fatemeh B, Bagher L (2008) Serum uric acid levels and risk of metabolic syndrome in healthy adults. Endocri Pract 14: 298–304. PubMed

Heinig M, Johnson RJ (2006) Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med 73: 1059–1064. PubMed

Tang W, Miller MB, Rich SS, North KE, Pankow JS, et al. (2003) National Heart, Lung, and Blood Institute Family Heart Study, Linkage analysis of a composite factor for the multiple metabolic syndrome. The National Heart, Lung, and Blood Institute Family Heart Study. Diabetes 52: 2840–2847. PubMed

Wilk JB, Djousse L, Borecki I, Atwood LD, Hunt SC, et al. (2000) Segregation analysis of serum uric acid in the NHLBI Family Heart Study. Hum Genet 106: 355–359. PubMed

Nath SD, Voruganti VS, Arar NH, Thameem F, Lopez-Alvarenga JC, et al. (2007) Genome scan for determinants of serum uric acid variability. J Am Soc Nephrol 18: 3156–3163. PubMed

Yang Q, Guo CY, Cupples LA, Levy D, Wilson PW, et al. (2005) Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart Study. Metabolism 54: 1435–1441. PubMed

Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, et al. (2002) Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417: 447–452. PubMed

Döring A, Gieger C, Mehta D, Gohlke H, Prokisch H, et al. (2008) SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 40: 430–436. PubMed

Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, et al. (2008) SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 40: 437–442. PubMed

Hollis-Moffatt JE, Xu X, Dalbeth N, Merriman ME, Topless R, et al. (2009) Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Maori, Pacific Island, and Caucasian case-control sample sets. Arthritis Rheum 60: 3485–3492. PubMed

Ichida K, Hosoyamada M, Hisatome I, Enomoto A, Hikita M, et al. (2004) Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol 15: 164–173. PubMed

Matsuo H, Chiba T, Nagamori S, Nakayama A, Domoto H, et al. (2008) Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J Hum Genet 83: 744–751. PubMed PMC

Anzai N, Ichida K, Jutabha P, Kimura T, Babu E, et al. (2008) Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J Biol Chem 283: 26834–26838. PubMed

Dinour D, Gray NK, Campbell S, Shu X, Sawyer L, et al. (2010) Homozygous SLC2A9 mutations cause severe renal hypouricemia. J Am Soc Nephrol 21: 64–72. PubMed PMC

Stiburkova B, Ichida K, Sebesta I (2011) Novel homozygous insertion in SLC2A9 gene caused renal hypouricemia. Mol Genet Metab 102: 430–435. PubMed

Stiburkova B, Taylor J, Marinaki AM, Sebesta I (2012) Acute kidney injury in two children caused by renal hypouricaemia type 2. Pediatr Nephrol 27: 1411–1415. PubMed

Stiburkova B, Sebesta I, Ichida K, Nakamura M, Hulkova H, et al. (2013) Novel allelic variants and evidence for a prevalent mutation in URAT1 causing renal hypouricemia: biochemical, genetics and functional analysis. Eur J Hum Genet 21: 1067–1073. PubMed PMC

Ekaratanawong S, Anzai N, Jutabha P, Miyazaki H, Noshiro R, et al. (2004) Human organic anion transporter 4 is a renal apical organic anion/dicarbo-xylate exchanger in the proximal tubules. J Pharmacol Sci 94: 297–304. PubMed

Bahn A, Hagos Y, Reuter S, Balen D, Brzica H, et al. (2008) Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13). J Biol Chem 283: 16332–16341. PubMed

Matsuo H, Takada T, Ichida K, Nakamura T, Nakayama A, et al. (2009) Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med 1: 5ra11. PubMed

Woodward OM, Köttgen A, Coresh J, Boerwinkle E, Guggino WB, et al. (2009) Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci U S A 106: 10338–10342. PubMed PMC

Jutabha P, Anzai N, Kitamura K, Taniguchi A, Kaneko S, et al. (2010) Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate. J Biol Chem 285: 35123–35132. PubMed PMC

Chong SS, Kristjansson K, Zoghbi HY, Hughes MR (1993) Molecular cloning of the cDNA encoding a human renal sodium phosphate transport protein and its assignment to chromosome 6p21.3–p23. Genomics 18: 355–359. PubMed

Urano W, Taniguchi A, Anzai N, Inoue E, Kanai Y, et al. (2010) Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout. Ann Rheum Dis 69: 1232–1234. PubMed

Sekine T, Watanabe N, Hosoyamada M, Kanai Y, Endou H (1997) Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 272: 18526–18529. PubMed

Eraly SA, Vallon V, Rieg T, Gangoiti JA, Wikoff WR, et al. (2008) Multiple organic anion transporters contribute to net renal excretion of uric acid. Physiol Genomics 33: 180–192. PubMed PMC

Anzai N, Kanai Y, Endou H (2007) New insights into renal transport of urate. Curr Opin Rheumatol 19: 151–157. PubMed

Janosikova B, Pavlikova M, Kocmanova D, Vitova A, Vesela K, et al. (2003) Genetic variants of homocysteine metabolizing enzymes and the risk of coronary artery disease. Mol Genet Metab 79: 167–175. PubMed

Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, et al. (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20: 895–900. PubMed

R Development Core Team (2013) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org

Vazquez-Mellado J, Jimenez-Vaca AL, Cuevas-Covarrubias S, Alvarado-Romano V, Pozo-Molina G, et al. (2007) Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford) 46: 215–219. PubMed

Tin A, Woodward OM, Kao WH, Liu CT, Lu X, et al. (2011) CARe and CHARGE Consortia (2011) Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele. Hum Mol Genet 20: 4056–4068. PubMed PMC

Li C, Han L, Levin AM, Song H, Yan S, et al. (2010) Multiple single nucleotide polymorphisms in the human urate transporter 1 (hURAT1) gene are associated with hyperuricaemia in Han Chinese. J Med Genet 47: 204–210. PubMed

Torres RJ, De Miguel E, Bailen R, Puig JG (2012) Absence of SLC22A12/URAT1 gene mutations in patients with primary gout. J Rheumatol 39: 1901. PubMed

Yakut S, Cetin Z, Arman M, Akbas H, Manguoglu AE, et al. (2013) Absence of the SLC22A12 gene mutation in Turkish population with primary gout disease. Rheumatol Int 33: 2921–2925. PubMed

Dehghan A, Köttgen A, Yang Q, Hwang SJ, Kao WL, et al. (2008) Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 372: 1953–1961. PubMed PMC

Tu HP, Chen CJ, Tovosia S, Ko AM, Lee CH, et al. (2010) Associations of a non-synonymous variant in SLC2A9 with gouty arthritis and uric acid levels in Han Chinese subjects and Solomon Islanders. Ann Rheum Dis 69: 887–890. PubMed

Hollis-Moffatt JE, Gow PJ, Harrison AA, Highton J, Jones PB, et al. (2011) The SLC2A9 nonsynonymous Arg265His variant and gout: evidence for a population-specific effect on severity. Arthritis Res Ther 13: R85. PubMed PMC

Sulem P, Gudbjartsson DF, Walters GB, Helgadottir HT, Helgason A, et al. (2011) Identification of low-frequency variants associated with gout and serum uric acid levels. Nat Genet 43: 1127–1130. PubMed

Li C, Chu N, Wang B, Wang J, Luan J, et al. (2012) Polymorphisms in the Presumptive Promoter Region of the SLC2A9 Gene Are Associated with Gout in a Chinese Male Population. PLoS ONE 7: e24561. PubMed PMC

Karns R, Zhang G, Sun G, Rao Indugula S, Cheng H, et al. (2012) Genome-wide association of serum uric acid concentration: replication of sequence variants in an island population of the Adriatic coast of Croatia. Ann Hum Genet 76: 121–127. PubMed PMC

McArdle PF, Parsa A, Chang YP, Weir MR, O'Connell JR, et al. (2008) Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order amish. Arthritis Rheum 58: 2874–2881. PubMed PMC

Kimura T, Takahashi M, Yan K, Sakurai H (2014) Expression of SLC2A9 isoforms in the kidney and their localization in polarized epithelial cells. PloS One 9: e84996. PubMed PMC

Augustin R, Carayannopoulos MO, Dowd LO, Phay JE, Moley JF, et al. (2004) Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J Biol Chem 279: 16229–16236. PubMed

Takiue Y, Hosoyamada M, Kimura M, Saito H (2011) The effect of female hormones upon urate transport systems in the mouse kidney. Nucleosides Nucleotides Nucleic Acids 30: 113–119. PubMed

A genome-wide association analysis reveals new pathogenic pathways in gout

Examining the Association of Rare Allelic Variants in Urate Transporters SLC22A11, SLC22A13, and SLC17A1 with Hyperuricemia and Gout

Functional Characterization of Rare Variants in OAT1/SLC22A6 and OAT3/SLC22A8 Urate Transporters Identified in a Gout and Hyperuricemia Cohort

Renal Hypouricemia 1: Rare Disorder as Common Disease in Eastern Slovakia Roma Population

Circulating microRNA alternations in primary hyperuricemia and gout

Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout

Evaluation of the Influence of Genetic Variants of SLC2A9 (GLUT9) and SLC22A12 (URAT1) on the Development of Hyperuricemia and Gout

Functional Characterization of Clinically-Relevant Rare Variants in ABCG2 Identified in a Gout and Hyperuricemia Cohort

The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients

A heterozygous variant in the SLC22A12 gene in a Sri Lanka family associated with mild renal hypouricemia

Functional analysis of novel allelic variants in URAT1 and GLUT9 causing renal hypouricemia type 1 and 2